BioSpace News Archive

Deals

Alcon Debuts as Independent, Publicly Traded Company

Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced its debut as an independent, publicly traded company and the completion of its separation from Novartis.

April 9, 2019
·
7 min read
Business

Vifor Pharma and Akebia Therapeutics Announce Expansion of Licence Agreement - April 9, 2019

Expanded licence creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA approval

April 9, 2019
·
6 min read
Business

Vifor Pharma and Akebia Therapeutics Announce Expansion of License Agreement

Expanded licence creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA approval

April 9, 2019
·
6 min read
Business

Orgentec Diagnostika Appoints Global Healthcare Leader Gary Winer As President And CEO

Orgentec Diagnostika, a leading specialty diagnostics company, announced today that its board of directors has appointed Gary Winer to president and chief executive officer, effective immediately.

April 9, 2019
·
3 min read
BerGenBio to Present at H.C. Wainwright Global Life Sciences Conference

BerGenBio ASA announces that Richard Godfrey, BerGenBio’s Chief Executive Officer, will present an overview of the Company at the H.C. Wainwright Global Life Sciences Conference, April 9, 2019.

April 9, 2019
·
2 min read
Drug Development

Poxel and Sumitomo Dainippon Pharma Announce Positive Top-Line Results for Imeglimin Phase 3 Trial (TIMES 1) in Japan for the Treatment of Type 2 Diabetes

Imeglimin Phase 3 TIMES 3 16-week, double-blind, placebo controlled, randomized part of the trial is expected to report data mid-year and TIMES 2 and full results from the TIMES 3 trials are anticipated to report top-line results around the end of 2019

April 9, 2019
·
9 min read
NSW Health in Australia Orders Radiology Solution From Sectra for Enterprise Access to Images

Medical imaging IT and cybersecurity company Sectra has signed a 13-year contract with NSW Health in Australia for an enterprise radiology imaging solution across Australia’s largest public health system.

April 9, 2019
·
4 min read
Business

NPI Hires Tara L. Kelly as Global Executive Assistant to Help Oversee Domestic and International Operations

Mitch Gould, founder and CEO of Nutritional Products International, announced this week the recent hiring of Tara L. Kelly as NPI’s Global Executive Assistant to help oversee the operations of NPI.

April 9, 2019
·
2 min read
Business

New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer’s disease, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.

New government research grant funds targeted at infectious agents will accelerate investigations into the possible roles of germs in triggering or promoting Alzheimer’s disease,” says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

April 9, 2019
·
2 min read
Nanna Therapeutics Awarded £829,892 Innovate UK Grant to Discover Novel Drugs Leveraging Its Nanoscale Medicines Discovery Engine

Expands Scientific Advisory Board with Appointment of Prof. David Spring

April 9, 2019
·
3 min read